Abstract
We report a case of Castleman’s disease that developed tumor lysis syndrome spontaneously and after systemic chemotherapy. A 44-year-old male patient was admitted with a 2-week history of abdominal distension accompanied by dyspnea. Physical examination revealed multiple lymph node enlargements. After admission, spontaneous hemoperitoneum developed and he underwent exploratory laparotomy, with the removal of the ruptured spleen. Pathologic review of the splenic tissue and excised lymph node gave the diagnosis of multicentric Castleman’s disease. He experienced two episodes of tumor lysis syndrome, initially spontaneous and then chemotherapy related, which needed vigorous management including hemodialysis and intensive fluid therapies. To our knowledge, this is the first reported case of Castleman’s disease complicated by tumor lysis syndrome. This suggests that the possibility of tumor lysis syndrome should be considered when treating Castleman’s disease with a large disease burden.
References
Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia. Cancer 9:822–830
Keller A, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670–683
McCarthy MJ, Vukelja SJ, Banks PM, Weiss RB (1995) Angiofollicular lymph node hyperplasia (Castleman’s disease). Cancer Treat Rev 21:291–310
Greiner T, Armitage JO, Gross TG (2000) Atypical lymphoproliferative disease. In: Schechter GP, Berliner N, Telen MJ (eds) The American Society of Hematology education program book. pp 133–146
Chronowsk GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD (2001) Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92:670–676
Warrell RP Jr (2001) Metabolic emergencies. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott, Philadelphia, pp 2633–2645
Levin M, Cho S (1996) Acute tumor lysis syndrome in high grade lymphoblastic lymphoma after prolonged episode of fever. Med Pediatr Oncol 26:417–418
Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, PIette JC, Raphael M (2002) Castleman’s disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 69:119–126
Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V (2002) High incidence of Kaposi-sarcoma associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331–2336
Advani R, Warnke R, Rosenberg S (1999) Treatment of multicentric Castleman’s disease complicated by the development of non-Hodgkin’s lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. Ann Oncol 10:1207–1209
Abdel-Reheim FA, Koss W, Rappaport ES, Arber DA (1996) Coexistence of Hodgkin’s disease and giant lymph node hyperplasia of the plasma-cell type (Castleman’s disease). Arch Pathol Lab Med 120:91–96
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, KD., Lee, KW., Choi, I.S. et al. Multicentric Castleman’s disease complicated by tumor lysis syndrome. Ann Hematol 83, 722–725 (2004). https://doi.org/10.1007/s00277-004-0923-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0923-2